En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood & Blood Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Point-Of-Care Testing

Browse Products by Category

Close

Lumos Diagnostics Holdings Ltd

Lumos Diagnostics Holdings Ltd

Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platform ...
Products Covid-19Summary
Close

Covid-19 Lumos Diagnostics Holdings Ltd

Clinical Laboratory

SARS-CoV-2 Rapid Antigen Test
CoviDx

CoviDx SARS-CoV-2 Rapid Antigen Test is a lateral flow assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs and nasopharyngeal swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first five days of symptoms. CoviDx SARS-CoV-2 Rapid Antigen Test is CE marked and is available in specific global markets in compliance with country requirements.
More details
Close

About Lumos Diagnostics Holdings Ltd

Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. Lumos also directly develops, manufactures and commercializes novel Lumos-branded POC tests that target infectious and inflammatory diseases.

Recently updated

Reusable Readers
Lumos Reusable Readers

Lumos has drawn upon its range of optical detector technologies, to configure a range of POC reader platforms for devices needing an objective test result. The Lumos reusable reader platform uses high precision camera optics and enables imaging of the entire test strip. There are no moving parts in the reusable reader, reducing the cost and complexity of the device. It is also suitable for qualitative and quantitative applications and a variety of assay detector chemistries (i.e. visual, fluorescent labels). Additional tests can be added post launch through a simple software update.
More details

Disposable Readers
Lumos Disposable Readers

Lumos has drawn upon its range of optical detector technologies, to configure a range of POC reader platforms for devices needing an objective test result. The Lumos disposable reader platform has been designed for easy drop in of test strips and uploading of custom assay specific analysis algorithms. These readers can easily be customized to meet users’ needs, with optional colorimetric or fluorescent labels, on-device LED indicator or LCD numerical results outputs, qualitative and quantitative options and Bluetooth connectivity for reporting of results via a smartphone or tablet.
More details

SARS-CoV-2 Rapid Antigen Test
CoviDx

CoviDx SARS-CoV-2 Rapid Antigen Test is a lateral flow assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs and nasopharyngeal swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first five days of symptoms. CoviDx SARS-CoV-2 Rapid Antigen Test is CE marked and is available in specific global markets in compliance with country requirements.
More details

Critical Care

POC Respiratory Infection Test
FebriDx

FebriDx is a rapid point-of-care test that uses a fingerstick blood sample to detect and aid in differentiating bacterial from viral acute respiratory infection. FebriDx results are available in 10 minutes, allowing the clinician to provide a timely and targeted treatment plan during the initial office visit.
More details

Clinical Laboratory

Reusable Readers
Lumos Reusable Readers

Lumos has drawn upon its range of optical detector technologies, to configure a range of POC reader platforms for devices needing an objective test result. The Lumos reusable reader platform uses high precision camera optics and enables imaging of the entire test strip. There are no moving parts in the reusable reader, reducing the cost and complexity of the device. It is also suitable for qualitative and quantitative applications and a variety of assay detector chemistries (i.e. visual, fluorescent labels). Additional tests can be added post launch through a simple software update.
More details

Disposable Readers
Lumos Disposable Readers

Lumos has drawn upon its range of optical detector technologies, to configure a range of POC reader platforms for devices needing an objective test result. The Lumos disposable reader platform has been designed for easy drop in of test strips and uploading of custom assay specific analysis algorithms. These readers can easily be customized to meet users’ needs, with optional colorimetric or fluorescent labels, on-device LED indicator or LCD numerical results outputs, qualitative and quantitative options and Bluetooth connectivity for reporting of results via a smartphone or tablet.
More details

SARS-CoV-2 Rapid Antigen Test
CoviDx

CoviDx SARS-CoV-2 Rapid Antigen Test is a lateral flow assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs and nasopharyngeal swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first five days of symptoms. CoviDx SARS-CoV-2 Rapid Antigen Test is CE marked and is available in specific global markets in compliance with country requirements.
More details

POC Respiratory Infection Test
FebriDx

FebriDx is a rapid point-of-care test that uses a fingerstick blood sample to detect and aid in differentiating bacterial from viral acute respiratory infection. FebriDx results are available in 10 minutes, allowing the clinician to provide a timely and targeted treatment plan during the initial office visit.
More details

Point-of-Care Assays
Point-of-Care Assays

Lumos has specific expertise in developing assays across a range of POC, chemistry and technology platforms. These can be configured as stand-alone, manual-read products or interfaced with Lumos readers or third-party hardware for fully automated solutions.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions